Marathon Capital Management
IBB icon

Marathon Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Marathon Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$289K Hold
1,375
– – 0.06% 150
2026
Q2 		$262K Sell
1,375
-1,275
-48% -$219K 0.05% 154
2026
Q1 		$447K Hold
2,650
– – 0.1% 112
2025
Q4 		$447K Sell
2,650
-165
-6% -$26.8K 0.1% 114
2025
Q3 		$406K Sell
2,815
-500
-15% -$68.2K 0.09% 109
2025
Q2 		$419K Sell
3,315
-300
-8% -$36.8K 0.11% 107
2025
Q1 		$462K Hold
3,615
– – 0.12% 98
2024
Q4 		$478K Hold
3,615
– – 0.12% 96
2024
Q3 		$526K Hold
3,615
– – 0.13% 92
2024
Q2 		$496K Hold
3,615
– – 0.13% 92
2024
Q1 		$496K Hold
3,615
– – 0.12% 94
2023
Q4 		$491K Hold
3,615
– – 0.12% 97
2023
Q3 		$442K Sell
3,615
-200
-5% -$25.4K 0.11% 96
2023
Q2 		$484K Sell
3,815
-100
-3% -$13K 0.12% 96
2023
Q1 		$506K Sell
3,915
-200
-5% -$26.2K 0.12% 98
2022
Q4 		$540K Buy
4,115
+100
+2% +$12.9K 0.15% 89
2022
Q3 		$470K Buy
+4,015
New +$499K 0.13% 98
2022
Q1 		– Sell
-3,715
Closed -$567K – 127
2021
Q4 		$567K Sell
3,715
-600
-14% -$92.9K 0.13% 99
2021
Q3 		$698K Sell
4,315
-500
-10% -$84.1K 0.16% 89
2021
Q2 		$787K Hold
4,815
– – 0.18% 72
2021
Q1 		$724K Hold
4,815
– – 0.19% 67
2020
Q4 		$729K Sell
4,815
-100
-2% -$14.3K 0.21% 65
2020
Q3 		$665K Hold
4,915
– – 0.24% 64
2020
Q2 		$672K Buy
+4,915
New +$627K 0.26% 56

Other funds holding IBB

WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return
MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
Investment House LLC
Investment House LLC Redondo Beach, California $2.25B AUM 30.44% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Redstone Wealth Management
Redstone Wealth Management Oklahoma City, Oklahoma $159M AUM 31.94% 1-Year Est. Return
Folger Nolan Fleming Douglas Capital Management
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return

Marathon Capital Management's IBB Position: Q3 2026 in Review

Marathon Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 1,375 shares worth $289K. The position accounts for 0.06% of the portfolio, ranked #150.

Marathon Capital Management first reported a position in IBB in Q2 2020 and has held it in 24 quarters since. The position peaked at $787K in Q2 2021. 409 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Marathon Capital Management held 1,375 shares of iShares Biotechnology ETF worth $289K as of Q3 2026.
  • Marathon Capital Management left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.06% of Marathon Capital Management's portfolio in Q3 2026, its #150 holding.
  • Marathon Capital Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 24 quarters since.
  • Marathon Capital Management's iShares Biotechnology ETF position peaked at $787K in Q2 2021.
  • 409 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Marathon Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.